Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Microsomal Metabolism of Furosemide Evidence for the Nature of the Reactive Intermediate Involved in Covalent Binding

PETER J. WIRTH, CAROL J. BETTIS and WENDEL L. NELSON
Molecular Pharmacology September 1976, 12 (5) 759-768;
PETER J. WIRTH
Department of Pharmaceutical Sciences, University of Washington School of Pharmacy, Seattle, Washington 98195
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAROL J. BETTIS
Department of Pharmaceutical Sciences, University of Washington School of Pharmacy, Seattle, Washington 98195
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WENDEL L. NELSON
Department of Pharmaceutical Sciences, University of Washington School of Pharmacy, Seattle, Washington 98195
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Pathways for the cytochrome P-450 monooxygenase-mediated covalent binding of furosemide to microsomal protein were examined. Two pathways were considered: one leading to a highly electrophilic imine by C- or N-hydroxylation followed by dehydration, the other an epoxidation pathway leading to formation of an arene oxide. Microsomal covalent binding of [α-3H]furosemide, [35S]furosemide, [α-2H]furosemide, and [α,α'-H]furosemide was the same, indicating that formation of an imine intermediate is unlikely and that the α-carbon is not a site of metabolic activation. Covalent binding to microsomal protein was enhanced in the presence of an epoxide hydrase inhibitor, 1,2-epoxy-3,3,3-trichloropropane, and did not occur when tetrahydro[35S]furosemide was used as substrate. The results indicate that the covalent binding is mediated by an arene oxide intermediate. The potential significance of a subsequent rearrangement of the arene oxide to other electrophilic species cannot presently be evaluated. Furosemide covalent binding assay results using microsomes from the inbred C57BL/6N (B6) and DBA/2N (D2) strains of mice which had been treated with 3-methylcholanthrene and phenobarbital were compared. Phenobarbital treatment increased covalent binding (p < 0.05) and 3-methylcholanthrene treatment had no effect, suggesting that a cytochrome P-450, rather than P-448, pathway is predominantly involved in mediating the covalent binding of furosemide.

ACKNOWLEDGMENTS The authors express their sincere appreciation to Dr. Snorri Thorgeirsson, Section on Molecular Toxicology, Developmental Pharmacology Branch, National Instiute of Child Health and Human Development, for providing facilities to perform the experiments using various strains of mice. The authors thank Dr. Thorgeirsson and Dr. Jerry R. Mitchell for helpful discussions about this work.

  • Copyright © 1976 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 12, Issue 5
1 Sep 1976
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Microsomal Metabolism of Furosemide Evidence for the Nature of the Reactive Intermediate Involved in Covalent Binding
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Microsomal Metabolism of Furosemide Evidence for the Nature of the Reactive Intermediate Involved in Covalent Binding

PETER J. WIRTH, CAROL J. BETTIS and WENDEL L. NELSON
Molecular Pharmacology September 1, 1976, 12 (5) 759-768;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Microsomal Metabolism of Furosemide Evidence for the Nature of the Reactive Intermediate Involved in Covalent Binding

PETER J. WIRTH, CAROL J. BETTIS and WENDEL L. NELSON
Molecular Pharmacology September 1, 1976, 12 (5) 759-768;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics